| Followers | 227 |
| Posts | 13589 |
| Boards Moderated | 0 |
| Alias Born | 03/15/2013 |
Thursday, June 06, 2024 4:25:32 PM
Someone loaded this just now
Recent KRMD News
- KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility • Business Wire • 03/13/2026 12:00:00 PM
- KORU Medical Systems Announces CEO Transition • Business Wire • 03/12/2026 08:08:00 PM
- KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance • Business Wire • 03/12/2026 08:05:00 PM
- KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • Business Wire • 02/26/2026 09:05:00 PM
- KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System • Business Wire • 01/29/2026 09:05:00 PM
- KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow • Business Wire • 01/12/2026 01:00:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/05/2026 12:00:00 PM
- KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic • Business Wire • 12/30/2025 09:05:00 PM
- KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer • Business Wire • 12/16/2025 09:05:00 PM
- KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 • Business Wire • 11/17/2025 09:05:00 PM
- KORU Medical Systems to Participate in Upcoming Investor Conferences • Business Wire • 11/13/2025 01:00:00 PM
- KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance • Business Wire • 11/12/2025 09:05:00 PM
- KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems • Business Wire • 11/04/2025 09:05:00 PM
- KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 • Business Wire • 10/22/2025 08:05:00 PM
- ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy • Business Wire • 09/18/2025 12:00:00 PM
- Cirtec Medical Announces Appointment of New Chief Executive Officer • GlobeNewswire Inc. • 08/28/2025 04:59:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:26:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:24:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:23:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 03:18:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 08:11:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 08:08:43 PM
- KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance • Business Wire • 08/06/2025 08:05:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/01/2025 08:55:00 PM
- KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference • Business Wire • 07/30/2025 08:05:00 PM
